DK3240529T3 - Stabile farmaceutiske sammensætninger omfattende micafungin - Google Patents

Stabile farmaceutiske sammensætninger omfattende micafungin Download PDF

Info

Publication number
DK3240529T3
DK3240529T3 DK15817912.7T DK15817912T DK3240529T3 DK 3240529 T3 DK3240529 T3 DK 3240529T3 DK 15817912 T DK15817912 T DK 15817912T DK 3240529 T3 DK3240529 T3 DK 3240529T3
Authority
DK
Denmark
Prior art keywords
micafungin
pharmaceutical compositions
compositions including
stable pharmaceutical
stable
Prior art date
Application number
DK15817912.7T
Other languages
English (en)
Inventor
Hidalgo Sergio Arroyo
Original Assignee
Galenicum Health S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52134071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3240529(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galenicum Health S L U filed Critical Galenicum Health S L U
Application granted granted Critical
Publication of DK3240529T3 publication Critical patent/DK3240529T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
DK15817912.7T 2014-12-31 2015-12-30 Stabile farmaceutiske sammensætninger omfattende micafungin DK3240529T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14200697 2014-12-31
PCT/EP2015/081384 WO2016107890A1 (en) 2014-12-31 2015-12-30 Stable pharmaceutical compositions comprising micafungin

Publications (1)

Publication Number Publication Date
DK3240529T3 true DK3240529T3 (da) 2022-02-28

Family

ID=52134071

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15817912.7T DK3240529T3 (da) 2014-12-31 2015-12-30 Stabile farmaceutiske sammensætninger omfattende micafungin

Country Status (5)

Country Link
EP (1) EP3240529B1 (da)
DK (1) DK3240529T3 (da)
ES (1) ES2777942T3 (da)
PL (1) PL3240529T3 (da)
WO (1) WO2016107890A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180169180A1 (en) * 2016-12-16 2018-06-21 Baxter International Inc. Micafungin compositions
US20220040092A1 (en) * 2020-06-27 2022-02-10 RK Pharma Solutions LLC Ready to use injectable formulations of Micafungin Sodium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
JP2006069929A (ja) 2004-08-31 2006-03-16 Konica Minolta Medical & Graphic Inc 真菌症治療製剤およびその製造方法
CN102614491B (zh) * 2011-01-31 2014-04-16 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途

Also Published As

Publication number Publication date
EP3240529B1 (en) 2022-02-02
ES2777942T1 (es) 2020-08-06
WO2016107890A1 (en) 2016-07-07
PL3240529T3 (pl) 2022-05-02
ES2777942T3 (es) 2022-04-22
EP3240529A1 (en) 2017-11-08

Similar Documents

Publication Publication Date Title
DK3529248T3 (da) Farmaceutiske sammensætninger
DK3361870T3 (da) Fungicidsammensætninger
HK1225655A1 (zh) 包含azd9291的藥用組合物
DK3236943T3 (da) Sammensætninger til ileo-jejunal lægemiddeladministration
DK3536380T3 (da) Hurtigtvirkende insulinsammensætninger
DK3233108T3 (da) Hurtigtvirkende insulinsammensætninger
BR112016023628A2 (pt) composições farmacêuticas.
DK3215173T3 (da) Glycopeptidsammensætninger
BR112016026879A2 (pt) Composição farmacêutica líquida
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3334726T3 (da) Plinabulinsammensætninger
FR3024363B1 (fr) Composition thermogelifiable
DK3250182T3 (da) Dispergible sammensætninger
DK3199161T3 (da) Farmaceutisk præparat
DK3129007T3 (da) Vaccinesammensætninger
CL2017000639A1 (es) Composición
DK3191085T3 (da) Misbrugsresistente farmaceutiske sammensætninger
DK3316857T3 (da) Multifasiske sammensætninger
DK3280447T3 (da) Farmaceutiske formuleringer
DK3200827T3 (da) Sammensætninger
DK3554474T3 (da) Micafungin-sammensætninger
DK3337322T3 (da) Fungicidsammensætninger
DK3217964T3 (da) Sammensætning
DK3148513T3 (da) Ceritinib-formulering
FR3019552B1 (fr) Composition filmogene